Esther Berrocoso Selected Research

Designer Drugs

1/2022	Nerve injury induces transient locus coeruleus activation over time: role of the locus coeruleus-dorsal reticular nucleus pathway.
1/2022	Pain and depression comorbidity causes asymmetric plasticity in the locus coeruleus neurons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esther Berrocoso Research Topics

Disease

31	Pain (Aches) 01/2022 - 09/2004
17	Neuralgia (Stump Neuralgia) 01/2022 - 07/2006
10	Chronic Pain 01/2022 - 01/2006
5	Hyperalgesia 01/2022 - 03/2011
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2019
3	Hypersensitivity (Allergy) 01/2017 - 01/2012
3	Mood Disorders (Mood Disorder) 06/2014 - 06/2004
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2018
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2021
2	Inflammation (Inflammations) 09/2021 - 01/2021
2	Arthritis (Polyarthritis) 01/2017 - 09/2011
2	Treatment-Resistant Depressive Disorder 01/2016 - 09/2009
2	Cognitive Dysfunction 04/2013 - 01/2013
2	Chronic Disease (Chronic Diseases) 05/2012 - 03/2011
1	Disease Progression 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Acute Pain 01/2022
1	Gliosis 09/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Insulin Resistance 11/2013
1	Body Weight (Weight, Body) 11/2013
1	Dementia (Dementias) 11/2013
1	Alzheimer Disease (Alzheimer's Disease) 04/2013

Drug/Important Bio-Agent (IBA)

13	Opioid Analgesics (Opioids)IBA 01/2020 - 06/2004
13	Analgesics (Analgesic Drugs)IBA 01/2019 - 03/2005
12	Antidepressive Agents (Antidepressants)IBA 09/2021 - 06/2004
7	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 03/2005
6	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 03/2011
4	Opioid Receptors (Opioid Receptor)IBA 06/2019 - 07/2007
4	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 12/2018 - 07/2006
4	Tramadol (K315)FDA LinkGeneric 12/2017 - 09/2004
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017 - 06/2014
3	Biological ProductsIBA 01/2022 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2013
3	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2018 - 01/2012
3	Freund's AdjuvantIBA 01/2017 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	Designer DrugsIBA 01/2022 - 01/2022
2	AntioxidantsIBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 06/2019 - 01/2019
2	Desipramine (Pertofrane)FDA LinkGeneric 12/2018 - 10/2016
2	N-Methylaspartate (NMDA)IBA 01/2018 - 09/2013
2	Tapentadol FDA Link 01/2018 - 09/2013
2	Morphine (MS Contin)FDA LinkGeneric 01/2018 - 09/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 11/2016
2	Opiate AlkaloidsIBA 11/2017 - 01/2006
2	Glutamic Acid (Glutamate)FDA Link 09/2013 - 01/2012
2	Serotonin and Noradrenaline Reuptake InhibitorsIBA 09/2011 - 03/2011
2	Milnacipran (Ixel)FDA Link 09/2011 - 03/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	ProlactinIBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2022
1	ezrinIBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	radixinIBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	beta Adrenergic ReceptorsIBA 01/2019
1	Histamine AgentsIBA 01/2019
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2019
1	Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2018
1	AcidsIBA 01/2018
1	CannabinoidsIBA 11/2017
1	MitogensIBA 01/2017
1	Mitogen-Activated Protein Kinase 3IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	DSP 4 (DSP-4)IBA 10/2016
1	AcetoneIBA 10/2016
1	NeurotoxinsIBA 10/2016
1	Bromodeoxyuridine (BrdU)IBA 10/2015
1	Corticotropin-Releasing HormoneIBA 02/2015
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2014
1	Diclofenac (SR 38)FDA LinkGeneric 06/2014
1	Insulin (Novolin)FDA Link 11/2013
1	Leptin ReceptorsIBA 11/2013
1	Glucose (Dextrose)FDA LinkGeneric 11/2013
1	BicucullineIBA 10/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2013
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 09/2013
1	Cholinergic Agents (Cholinergics)IBA 04/2013
1	Amyloid (Amyloid Fibrils)IBA 04/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013

Therapy/Procedure

10	Analgesia 01/2022 - 07/2007
2	Therapeutics 01/2020 - 12/2018
2	Drug Therapy (Chemotherapy) 12/2018 - 01/2006
2	Deep Brain Stimulation 01/2018 - 01/2016
2	Denervation 04/2013 - 01/2013
1	Electrodes (Electrode) 09/2021